CODEXIS INC Business Operations Contracts & Agreements
30 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (1)
- Indemnification Agreements (3)
- MOUs (6)
- Supply Agreements (19)
- Amendment No. 3 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (Filed With SEC on May 4, 2023)
- Amendment No. 2 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of February 1, 2023 (Filed With SEC on February 27, 2023)
- Amendment No. 1 to the Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, effective as of December 19, 2022 (Filed With SEC on February 27, 2023)
- Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals, dated as of July 14, 2022 (Filed With SEC on February 27, 2023)
- Form of Indemnification Agreement between the Company and each of its directors, officers and certain employees (Filed With SEC on February 27, 2023)
- Enzyme Supply Agreement by and between the Company and Pfizer Ireland Pharmaceuticals (Filed With SEC on November 4, 2022)
- Amendment No. 5 to Sitagliptin Supply Agreement, effective as of July 1, 2021, by and between Codexis, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on November 5, 2021)
- Letter Agreement, effective as of February 21, 2020, by and between Codexis, Inc. and GlaxoSmithKline Intellectual Property Development Limited (Filed With SEC on May 8, 2020)
- Strategic Collaboration and License Agreement, effective as of March 23,202, by and between Codexis, Inc. and Shire Human Genetic Therapies, Inc., a wholly-owned subsidiary of... (Filed With SEC on May 8, 2020)
- AMENDMENT NO. 4 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on November 8, 2016)
- AMENDMENT NO. 3 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on March 8, 2016)
- AMENDMENT NO. 2 TO SITAGLIPTIN SUPPLY AGREEMENT (Filed With SEC on May 7, 2015)
- AMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on November 12, 2013)
- SITAGLIPTIN CATALYST SUPPLY AGREEMENT By and Between MERCK SHARP AND DOHME CORP And CODEXIS, INC. SITAGLIPTIN CATALYST SUPPLY AGREEMENT (Filed With SEC on April 2, 2013)
- ENZYME SUPPLY AGREEMENT (Filed With SEC on April 2, 2013)
- AMENDMENT NO. 1 TO MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on May 10, 2012)
- AMENDMENT NO. 1 TO ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on March 5, 2012)
- AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (Filed With SEC on November 7, 2011)
- AMENDMENT NO. 1 TO MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (Filed With SEC on November 7, 2011)
- MANUFACTURE AND SUPPLY AGREEMENT (Filed With SEC on August 3, 2011)
- ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on April 16, 2010)
- MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (CODEXIS INDIA) (Filed With SEC on April 5, 2010)
- MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (CODEXIS INC.) (Filed With SEC on April 5, 2010)
- ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on April 5, 2010)
- CODEXIS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on March 31, 2010)
- MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING (CODEXIS INDIA) (Filed With SEC on February 26, 2010)
- MEMORANDUM OF UNDERSTANDING FOR TRANSFER PRICING AND ROYALTY CALCULATION (CODEXISINC.) (Filed With SEC on February 26, 2010)
- ENZYME AND PRODUCT SUPPLY AGREEMENT (Filed With SEC on February 26, 2010)
- PRODUCT SUPPLY AGREEMENT (Filed With SEC on February 26, 2010)
- INDEMNIFICATION AGREEMENT (Filed With SEC on December 28, 2009)